Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
FLOWSERVE CORP (FLS)
Sector: Industrials; Industry: Specialty Industrial Machinery

Flowserve Corporation designs, develops, manufactures, distributes, and services industrial flow management equipment in the United States, Europe, the Middle East, Africa, Asia, and internationally. The FPD segment offers custom and pre-configured pumps and pump systems, mechanical seals, auxiliary systems, replacement parts, upgrades, and related aftermarket services, including product installation and commissioning services, seal systems spare parts, repairs, re-rate and upgrade solutions, and machining and asset management solutions, as well as manufactures a gas-lubricated mechanical seal for use in high-speed compressors for gas pipelines. It primarily serves oil and gas, chemical and pharmaceuticals, power generation, and water management markets, as well as general industries, including mining and ore processing, pulp and paper, food and beverage, and other smaller applications. Flowserve Corporation was incorporated in 1912 and is headquartered in Irving, Texas.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-03-08 Wilson Kirk President, FCD Sell 10,000 $41.72 $417,213 No
2020-03-09 Chowbey Sanjay President, AMSS Buy 500 $30.38 $15,190 No
2020-03-03 Wilson Kirk President, FCD Sell 3,239 $40.63 $131,591 No
2020-02-24 Chand Sujeet Director Buy 1,000 $43.88 $43,879 No
2019-12-10 Minnix Lanesha SVP, Chief Legal Officer Sell 820 $47.97 $39,339 No
2019-06-07 Lenander John President, FCO Sell 5,761 $49.32 $284,152 No
2019-03-13 Lenander John President, FCO Sell 6,818 $44.75 $305,095 No
2017-02-28 OConnor Carey SVP, GC and Secretary Sell 10,500 $47.14 $495,002 No
2017-02-28 BLINN MARK A President & CEO Sell 42,500 $46.82 $1,989,985 No
2017-02-28 Pajonas Thomas L EVP, Chief Operating Officer Sell 25,000 $46.79 $1,169,660 No
2016-11-02 BLINN MARK A President & CEO Sell 119,232 $41.64 $4,964,367 No
2016-08-02 Pajonas Thomas L EVP, Chief Operating Officer Sell 35,000 $45.49 $1,592,104 No
2016-08-02 BLINN MARK A President & CEO Sell 84,261 $45.50 $3,834,052 Yes
2016-08-03 RUSNACK WILLIAM C Director Sell 2,169 $46.72 $101,326 No
2015-08-06 Gillespie Keith E. Chief Strategy & Admin Officer Buy 10,719 $46.60 $499,455 No
2015-08-07 RUSNACK WILLIAM C Director Sell 1,692 $46.71 $79,033 No
2015-02-20 Taff Michael S SVP and CFO Sell 30,000 $62.48 $1,874,415 No
2015-02-20 Pajonas Thomas L SVP, Chief Operating Officer Sell 40,000 $62.48 $2,499,220 No
2015-02-20 BLINN MARK A President & CEO Sell 69,000 $62.48 $4,311,154 No
2014-08-08 FIX ROGER L Director Sell 2,232 $72.02 $160,749 No
2014-07-30 RUSNACK WILLIAM C Director Sell 2,232 $75.98 $169,587 No
2014-04-28 DAILEY MARK D SVP and Chief Admin Ofcr Sell 18,000 $71.94 $1,294,839 No
2014-02-21 Stephens Dave SVP, Human Resources Sell 2,024 $81.32 $164,600 No
2014-02-21 Pajonas Thomas L SVP, Chief Operating Officer Sell 40,000 $81.31 $3,252,452 No
2014-02-21 BLINN MARK A President & CEO Sell 87,000 $81.31 $7,073,961 No
2014-02-21 OConnor Carey SVP, GC and Secretary Sell 6,135 $81.32 $498,902 No
2013-05-21 RUSNACK WILLIAM C Director Sell 1,216 $173.03 $210,406 No
2013-04-29 BLINN MARK A President & CEO Sell 28,000 $157.82 $4,418,942 No
2013-04-29 DAILEY MARK D SVP and Chief Admin Ofcr Sell 8,500 $157.82 $1,341,504 No
2013-04-29 Pajonas Thomas L SVP, Chief Operating Officer Sell 17,000 $157.82 $2,682,974 No

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.